ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto
Numéro d'article : BIOV2696-25
Unité de mesure : 25 MG
Fabricant : BIOVISION
Numéro du fabricant : 2696-25
Température de stockage : Freezer (-20)
ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto
Ihr dynamisches Snippet wird hier angezeigt ...
Diese Meldung wird angezeigt, weil Sie weder einen Filter noch eine Vorlage zur Verwendung bereitgestellt haben.